MOR

Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments

Retrieved on: 
Tuesday, January 3, 2023
Cancer, Partnership, MOR, Clalit Health Services, HMO, Research, Neoplasm, Technology transfer, Patient, Tumor microenvironment, Health maintenance organization, Drug resistance, Hospital, Humanitarian use licenses, Biotechnology, Escape Room, Pharmaceutical industry

The agreement provides Purple Biotech first access to early-stage oncology product candidates owned by Mor.

Key Points: 
  • The agreement provides Purple Biotech first access to early-stage oncology product candidates owned by Mor.
  • The research conducted at these hospitals is now potentially available to Purple Biotech for in-licensing and clinical development.
  • “To grow our pipeline of therapeutic assets, our focus at Purple Biotech is to identify unique, first-in-class oncology assets and technologies and bring them into clinical development,” said Gil Efron, CEO of Purple Biotech.
  • “We look forward to collaborating with Purple Biotech as a partner that can bring our high-value, first-in-class assets forward through further development,” said Shay Marcus, Mor Research Application's CEO.

atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

Retrieved on: 
Friday, December 23, 2022
Hypoventilation, Part, Pharmacokinetics, Respiratory rate, Research, MOR, Oxycodone, CPT, Entrepreneurship, Safety, Kurash, Respiration, Pharmaceutical industry

NEW YORK and BERLIN, Dec. 23, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai” or “the Company”), a clinical stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced additional clinical data from the Kures Therapeutics Phase 1 trial of KUR-101 in healthy volunteers. This two-part trial was designed to assess the safety, tolerability, pharmacokinetics, and analgesic activity of KUR-101.

Key Points: 
  • This two-part trial was designed to assess the safety, tolerability, pharmacokinetics, and analgesic activity of KUR-101.
  • Analgesic activity was assessed by the cold pressor test (CPT) and impact on respiration was evaluated by measuring respiration rate at multiple time points.
  • Part 2 consisted of a randomized, double-blind, crossover study to evaluate the safety and analgesic activity of KUR-101 compared to both oxycodone and placebo.
  • Further, both KUR-101 and oxycodone demonstrated effects on respiration comparable to placebo, thus precluding definitive conclusions of KUR-101’s respiratory impact.

The Missoula Organization of REALTORS® Partners with Endpoint Utility to Provide Critical IT Support

Retrieved on: 
Tuesday, November 1, 2022
CEO, MOR, Partnership, Industry, Endpoint, Five Valleys, Technology, Association, Solution, NMAR, Property management

"End User Support and Cyber Security are imperative for today's REALTORS in a complex IT world, and we are thrilled to be working with the Missoula Organization of REALTORS " says David Mayer, CEO and Co-founder.

Key Points: 
  • "End User Support and Cyber Security are imperative for today's REALTORS in a complex IT world, and we are thrilled to be working with the Missoula Organization of REALTORS " says David Mayer, CEO and Co-founder.
  • "We're excited about this partnership with Endpoint who understands needs and concerns of our members and the technology product offerings of our association" says Jim Bachand, CEO Missoula Organization of REALTORS .
  • Endpoint Utility provides an affordable, expertly managed set of technology solutions for customers that have been dramatically underserved by the current IT ecosystem.
  • About the Missoula Organization of REALTORS:
    The Missoula Organization of REALTORS (MOR) is a trade association dedicated to providing valuable programs, products, and services to members and affiliate members.

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD

Retrieved on: 
Wednesday, October 12, 2022
Oxycodone, Drug overdose, Pharmacology, CDC, Infection, U.S. Securities and Exchange Commission, Therapy, SEC, OUD, Methadone, Respiration, Hypoventilation, Annual report, Part, Patient, Part Two, Depression, Research, Opioid use disorder, Security (finance), Mental health, Nasdaq, Drug, Private Securities Litigation Reform Act, NEW, Columbia University, Addiction, Respiratory rate, MOR, Buprenorphine, CEO, Pain, Food, GLOBE, Anxiety, Public expenditure, PK, Intellectual property, Forward-looking statement, Naltrexone, Death, Failure, FDA, COVID-19, List of life sciences, Vaccine, Medicinal plants, Pharmaceutical industry, Kurash

NEW YORK and BERLIN, Oct. 12, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) announced today positive initial results for their Phase 1 clinical trial of KUR-101. KUR-101 is an oral formulation of deuterated mitragynine, the major active alkaloid of the kratom plant, under development for the treatment of opioid use disorder (OUD).

Key Points: 
  • KUR-101 is an oral formulation of deuterated mitragynine, the major active alkaloid of the kratom plant, under development for the treatment of opioid use disorder (OUD).
  • Approximately 3 million people in the U.S. are diagnosed with OUD, and relapse occurs in up to 75% of patients.
  • NEW YORK and BERLIN, Oct. 12, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (atai) announced today positive initial results for their Phase 1 clinical trial of KUR-101.
  • KUR-101 is an oral formulation of deuterated mitragynine, the major active alkaloid of the kratom plant, under development for the treatment of opioid use disorder (OUD).

Midwest Orthopaedics at Rush Broadens Reach of Pediatric Orthopedics to Joliet

Retrieved on: 
Monday, October 3, 2022
Houston Orthopedic and Spine Hospital, Rush University Medical Center, Northwestern Memorial Hospital, Female, Technology, Parent, MOR, Scoliosis, Lists of diseases, Mentorship, Elective surgery, Park Ridge, Birth, Clubfoot, Patient, Trauma, Dominican Republic, University, Primary Children's Hospital, Medical Center, Illinois College, News, Medicine, Dentistry, Orthopedic surgery

JOLIET, Ill., Oct. 3, 2022 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) today announces an expansion of its pediatric orthopedics presence that will broaden access for patients across the Chicagoland area. Dr. Monica Kogan, a MOR physician also serving as an assistant professor and director of the Pediatric Orthopedics program at Rush University Medical Center, is now practicing across three MOR locations including Chicago, Westchester and newly added, Joliet.

Key Points: 
  • JOLIET, Ill., Oct. 3, 2022 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) today announces an expansion of its pediatric orthopedics presence that will broaden access for patients across the Chicagoland area.
  • Dr. Monica Kogan, a MOR physician also serving as an assistant professor and director of the Pediatric Orthopedics program at Rush University Medical Center, is now practicing across three MOR locations including Chicago, Westchester and newly added, Joliet.
  • Dr. Kogan's added availability in Joliet continues to deliver on MOR's commitment to enhancing orthopedic treatment options for patients in the city as well as suburban Chicago.
  • "Dr. Kogan offers parents a world-class option for the treatment of their children's orthopedic conditions," said Dr. Brian Cole, managing partner of Midwest Orthopaedics at Rush.

Midwest Orthopaedics at Rush Enhances Clinical Expertise at Naperville and Joliet Locations with Addition of Two Leading Physicians

Retrieved on: 
Thursday, September 1, 2022
University, Back pain, Technology, Spine, DRS, Houston Orthopedic and Spine Hospital, Hand, City, News, Latin honors, Robotics, Northwestern University Dental School, Believer, Frederick Mors, University of Pittsburgh Medical Center, Feinberg School of Medicine, Physician, Neck, Wrist, Travel, U.S. News & World Report, Elbow, Ascending limb of loop of Henle, Patient, Arthritis, Park Ridge, MOR, UCLA, Motion, Health, Rush University Medical Center, Medical device, Pharmaceutical industry, Dentistry, Northwestern University, Mohamed Sayari, Orthopedic surgery, Economics

NAPERVILLE, Ill., Sept. 1, 2022 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) today announces an expansion of its presence in Joliet and Naperville with the hiring of two specialist physicians. Nitin Goyal, M.D. and Arash Sayari, M.D. will practice at both locations starting today, which will further elevate MOR's clinical expertise and enhance accessibility to world-class orthopedic care in DuPage, Kendall and Will counties.

Key Points: 
  • will practice at both locations starting today, which will further elevate MOR's clinical expertise and enhance accessibility to world-class orthopedic care in DuPage, Kendall and Will counties.
  • Goyal and Sayari each completed their residency with MOR and Rush University Medical Center before pursing fellowships at other world-renowned institutions.
  • Having grown up in Naperville, Dr. Goyal's clinical presence in the Chicagoland area holds a significant level of personal meaning.
  • To schedule an appointment with Dr. Goyal or Dr. Sayari at MOR locations in Joliet or Naperville, please visit www.rushortho.com or call 877.MD.BONES.

Riley Decker Companies Promotes Two Team Members to Vice President of Operations

Retrieved on: 
Thursday, August 18, 2022
Multimedia, Travel, Industry, CEO, American City Business Journals, Growth, Employment agency, Marketing, Engineering, Riley, Forecasting, Employment, MOR, Galaxy, Retail, Management, Operation, Cincinnati metropolitan area

CINCINNATI, Aug. 18, 2022 /PRNewswire/ -- Riley Decker Companies, a family of staffing brands and one of the largest staffing firms in the U.S., has announced the promotion of two team members responsible for leading operations for their skilled trades and healthcare brands.

Key Points: 
  • We are grateful for the business opportunities in front of us and are excited to recognize these employees who will play a critical part in our long-term success," said Kyle Decker, CEO & Founder, Riley Decker Companies.
  • Tiffany Feeley, former Director of Strategy for Riley Decker Companies, has been promoted to Vice President of Operations of MOR Talent Solutions.
  • Tessie Ward, former Director of Marketing for Riley Decker Companies, has been promoted to Vice President of Operations for Galaxy Healthcare.
  • Riley Decker Companies is a family of staffing brands servicing the light industrial, skilled trades, and healthcare staffing segments.

Inpria Co-Developing Metal Oxide Resist with SK hynix to Reduce Complexity of Patterning for Next-Generation DRAM

Retrieved on: 
Tuesday, August 2, 2022
Technology, Other Manufacturing, Semiconductor, Manufacturing, Industry, Semiconductor, DRAM, Adoption, JSR, Quality of life, Science, Acceleration, Society, Printing, EUV, MOR, 3D printing

JSR Corporation announced today acceleration of its co-development with SK hynix Inc. to apply Inpria, a JSR companys Extreme Ultraviolet (EUV) metal oxide resist (MOR) for manufacturing advanced DRAM chips.

Key Points: 
  • JSR Corporation announced today acceleration of its co-development with SK hynix Inc. to apply Inpria, a JSR companys Extreme Ultraviolet (EUV) metal oxide resist (MOR) for manufacturing advanced DRAM chips.
  • Inpria material solutions provide the performance needed to significantly reduce the cost of EUV patterning and are compatible with proven processes and equipment configurations.
  • EUV manufacturing is complex and requires cutting-edge materials, said BK Lee, head of R&D process at SK hynix.
  • Inpria is the leader in metal oxide EUV resists and has achieved the world's highest resolution using EUV exposure systems.

Midwest Orthopaedics at Rush Named Fifth Best Orthopedic Program In the Nation, Best in Illinois

Retrieved on: 
Wednesday, July 27, 2022
Chicago White Sox, Physician, Literature, Research, Patient safety, U.S. News & World Report, Houston Orthopedic and Spine Hospital, News, Park Ridge, Technology, Patient, Pain, Survival, MOR, Growth, Chicago Fire FC, Gold, Medicine, Chicago Bulls, Orthopedic surgery

CHICAGO, July 27, 2022 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) is pleased to announce its ranking as the fifth-best program in the nation for orthopedic surgery by U.S. News & World Report. The latest ranking builds upon MOR's 6th place position nationally in 2021 and demonstrates a continued commitment to excellence in quality of care and patient outcomes. The 2022 ranking also comes at an exciting time of growth for MOR as it continues to open new clinics throughout the greater Chicago-area, strengthen team physician affiliations with professional sports organizations and support impactful local initiatives in many of the communities it serves.

Key Points: 
  • Midwest Orthopaedics at Rush rises in 2022 rankings by U.S. News & World, enhancing an established tradition of excellence
    CHICAGO, July 27, 2022 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) is pleased to announce its ranking as the fifth-best program in the nation for orthopedic surgery by U.S. News & World Report.
  • The latest ranking builds upon MOR's 6th place position nationally in 2021 and demonstrates a continued commitment to excellence in quality of care and patient outcomes.
  • Other criteria used in the ranking were reputation with specialists, survival, patient safety, patient volume, nursing intensity and nurse magnet recognition.
  • To schedule an appointment with a Midwest Orthopaedics at Rush physician, visit www.rushortho.com or call 877.MD.BONES.

RENOWNED ORTHOPEDIC SURGEON TAKES TELEHEALTH TO A CONCIERGE LEVEL SAVING TIME AND MONEY FOR PATIENTS

Retrieved on: 
Thursday, July 21, 2022
Patient, Knowledge, Joffrey Ballet, Time, Environment, Education, MIT, Pleasure, Chicago Bulls, Physician, Health, Research, Rush University Medical Center, Chicago Tribune, Travel, BEST, Athlete, Multimedia, News, Movement, U.S. News & World Report, Ligament, Tendon, Transport, Mechanical, COVID, Chicago White Sox, Pain, 2001–02 Chicago Bulls season, MOR, Program, Mark (given name), Growth, Chicago Fire FC, Hip, Dentistry, Hospital, Medicine, Medical device

CHICAGO, July 21, 2022 /PRNewswire/ -- Pioneering orthopedic surgeon Dr. Richard Berger , M.D., of Midwest Orthopaedics at Rush (MOR), is taking telehealth to a new level with an unparalleled concierge telehealth program for hip and knee replacement patients.

Key Points: 
  • CHICAGO, July 21, 2022 /PRNewswire/ -- Pioneering orthopedic surgeon Dr. Richard Berger , M.D., of Midwest Orthopaedics at Rush (MOR), is taking telehealth to a new level with an unparalleled concierge telehealth program for hip and knee replacement patients.
  • Patients only need to travel to Chicago for a meeting with Dr. Berger followed by surgery the next day.
  • Additionally, the program allows patients' family members to conference in from all over the world prior to and following the surgery.
  • "With the rapid growth of telehealth, we want to foster an environment where patients feel like they are cared for more than ever.